Adjunct/Affiliated Professor
President, Gardner Law
“Mitchell Hamline’s nationally ranked Health Law Institute is a tremendous asset to the health care sector. The school takes advantage of its surroundings by calling on leaders in the community, which is an internationally recognized health care hub. Minnesota is home to a vibrant medical technology industry, known as ‘Medical Alley,’ and some of the largest insurers and most renowned health care systems in the world. The school trains and helps place many of the health care leaders of tomorrow.”
Experience
Mark Gardner, MBA, JD, president, Gardner Law is a drug and device lawyer. He’s an adjunct professor of drug and device law and a Health Law Institute advisory board member at Mitchell Hamline. Mark is a member of the ABA, FDLI and MSBA.
Former roles: product manager, chair of the Minnesota State Bar Association Food, Drug, and Device Law Section, and chair of Medical Alley Regulatory Special Interest Group. His practice focuses on FDA approval pathways; healthcare compliance assessments, design and implementation of compliance programs, investigations, and training; advertising and promotion review; business interactions with healthcare professionals; responding to and negotiating with regulators and prosecutors; sunshine reporting; quality and regulatory assessments; clinical research; and privacy matters.
Education
B.S., Economics and Finance (double major), University of Wisconsin-La Crosse
M.B.A., Venture Management, University of St. Thomas, Opus College of Business
J.D., Mitchell Hamline School of Law
